Bausch + Lomb Insider Trading
TSX: BLCO
6
All Trades
6
Significant
0
Notable
6
Clusters
0
Repeat
| Company | Insider | Title | Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|
| Bausch + Lomb | Bailey, Ambrose Robert Douglas | CLO | 06-Mar-26 | 14,600 | $17.15USD | $250,338 | 100,940 | 17% | Significant Cluster |
| Bausch + Lomb | Ross Sr., Thomas | Director | 03-Mar-26 | 4,500 | $17.68USD | $79,556 | 17,000 | 36% | Significant Cluster |
| Bausch + Lomb | Von Eschenbach, Andrew Charles | Director | 27-Feb-26 | 4,364 | $18.30USD | $79,883 | 18,559 | 31% | Significant Cluster |
| Bausch + Lomb | Collis, Steven Howard | Director | 23-Feb-26 | 15,000 | $17.81USD | $267,150 | 15,000 | New | Significant Strong Cluster |
| Bausch + Lomb | Robertson, Russel Clark | Director | 20-Feb-26 | 4,400 | $17.90USD | $78,760 | 10,208 | 76% | Significant Strong Cluster |
| Bausch + Lomb | Ling, Karen | Director | 19-Feb-26 | 4,000 | $17.74USD | $70,968 | 21,338 | 23% | Significant Strong Cluster |
Stock Chart
Related Companies to Explore
Company Info
Bausch + Lomb Corporation is a leading global eye health company headquartered in Vaughan, Ontario, Canada. One of the most recognized brands in the eye care industry with a history spanning over 170 years, Bausch + Lomb develops, manufactures, and markets a comprehensive portfolio of products including contact lenses, lens care products, ophthalmic pharmaceuticals, intraocular lenses, and surgical equipment. The company serves eye care professionals and consumers in over 100 countries worldwide. Bausch + Lomb was spun off from Bausch Health Companies and listed independently on the Toronto Stock Exchange under the ticker BLCO, providing investors with dedicated exposure to one of the world’s premier eye health franchises.